Nothing Special   »   [go: up one dir, main page]

SG11201911318SA - Moisturizing topical preparation - Google Patents

Moisturizing topical preparation

Info

Publication number
SG11201911318SA
SG11201911318SA SG11201911318SA SG11201911318SA SG11201911318SA SG 11201911318S A SG11201911318S A SG 11201911318SA SG 11201911318S A SG11201911318S A SG 11201911318SA SG 11201911318S A SG11201911318S A SG 11201911318SA SG 11201911318S A SG11201911318S A SG 11201911318SA
Authority
SG
Singapore
Prior art keywords
topical preparation
moisturizing
moisturizing topical
preparation
topical
Prior art date
Application number
SG11201911318SA
Inventor
Kotaro Ishikawa
Takuro Kashiwamura
Takuya Kato
Toru Koga
Suguru Ishikawa
Original Assignee
Oji Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oji Holdings Corp filed Critical Oji Holdings Corp
Publication of SG11201911318SA publication Critical patent/SG11201911318SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201911318SA 2017-05-31 2018-05-30 Moisturizing topical preparation SG11201911318SA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017108001 2017-05-31
JP2017175133 2017-09-12
JP2017244051 2017-12-20
PCT/JP2018/020644 WO2018221547A1 (en) 2017-05-31 2018-05-30 Moisturizing topical preparation

Publications (1)

Publication Number Publication Date
SG11201911318SA true SG11201911318SA (en) 2020-01-30

Family

ID=64455406

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201911318SA SG11201911318SA (en) 2017-05-31 2018-05-30 Moisturizing topical preparation
SG10201913607WA SG10201913607WA (en) 2017-05-31 2018-05-30 Moisturizing topical preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201913607WA SG10201913607WA (en) 2017-05-31 2018-05-30 Moisturizing topical preparation

Country Status (12)

Country Link
US (1) US11278485B2 (en)
EP (1) EP3632451A4 (en)
JP (1) JP6555431B2 (en)
KR (2) KR20240023711A (en)
CN (1) CN110678189A (en)
AU (1) AU2018276567B2 (en)
BR (1) BR112019025030A2 (en)
CA (1) CA3065747A1 (en)
MX (1) MX2019014445A (en)
PH (1) PH12019502676A1 (en)
SG (2) SG11201911318SA (en)
WO (1) WO2018221547A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3683242B1 (en) * 2017-09-12 2024-10-30 Oji Holdings Corporation Pentosan polysulfate and method for producing pentosan polysulfate
PT3730521T (en) 2017-12-20 2023-06-19 Oji Holdings Corp Pentosan polysulfate and medicine containing pentosan polysulfate
WO2019151286A1 (en) * 2018-01-31 2019-08-08 マルホ株式会社 Topical dermatological composition
TW201940177A (en) * 2018-01-31 2019-10-16 日商瑪路弘股份有限公司 External composition for skin
TW201940179A (en) * 2018-01-31 2019-10-16 日商瑪路弘股份有限公司 Skin composition for external use
WO2022114111A1 (en) * 2020-11-27 2022-06-02 マルホ株式会社 Pharmaceutical or cosmetic composition

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4843100B1 (en) 1969-09-05 1973-12-17
US4168742A (en) 1978-03-27 1979-09-25 Hudson Products Corporation Tube bundle
FR2538404B1 (en) 1982-12-28 1985-08-23 Anic Spa
FR2543145B1 (en) 1983-03-24 1986-10-17 Sanofi Sa NOVEL XYLAN SULPHATES, THEIR PREPARATION PROCESS AND THEIR ANTI-THROMBOTIC AND HYPOLIPEMIC ACTIVITY
JPS60112708A (en) 1983-11-24 1985-06-19 Maruho Kk Humectant for skin
FR2572731B1 (en) 1984-11-07 1987-03-06 Sanofi Sa NOVEL LOW MOLECULAR WEIGHT XYLAN SULPHATES, PROCESS FOR THEIR PREPARATION AND ORAL ANTITHROMBOTIC AND HYDROPHOLIC ACTIVITY
JPS61130301A (en) 1984-11-30 1986-06-18 Tokyo Univ Xylofuranan sulfate having anticoagulant activity and its production
JPS61130302A (en) 1984-11-30 1986-06-18 Tokyo Univ Ribofuranan sulfate having anticoagulant activity and its production
JPS624362A (en) 1985-07-01 1987-01-10 Victor Co Of Japan Ltd Solid-state image pickup device
US5672334A (en) 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
FR2645745B1 (en) 1989-04-12 1991-09-27 Anben Ste Civile THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF SNORING
DE3917982A1 (en) 1989-06-02 1990-12-06 Behringwerke Ag USE OF XYLANPOLYHYDROGENSULFATES FOR THE THERAPY OF CELL PROBLEMATION-RELATED DISEASES
FR2648463B1 (en) 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer SULPHATE POLYSACCHARIDES, ANTICOAGULATING AGENT AND ANTI-COMPLEMENTARY AGENT OBTAINED FROM BROWN ALGAE FUCANES AND PROCESS FOR OBTAINING SAME
WO1991016058A1 (en) 1990-04-26 1991-10-31 Cytrx Corporation Composition and method for topical treatment of damaged or diseased tissue
US20010005720A1 (en) 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
DE19632840A1 (en) * 1996-08-14 1998-02-19 Landsberger Albert Composition containing vitamin A
JPH10195107A (en) 1997-01-10 1998-07-28 Shiseido Co Ltd Sulfated oligohyaluronic acid
JP4336905B2 (en) * 1997-12-19 2009-09-30 マルホ株式会社 Skin moisturizing emulsion lotion containing sulfated polysaccharide
US6593310B1 (en) 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
DE10141106A1 (en) * 2001-08-22 2003-03-13 Aventis Pharma Gmbh Use of heparinoid derivatives for the treatment and diagnosis of heparinoid-treatable diseases
JP4073661B2 (en) 2001-12-20 2008-04-09 王子製紙株式会社 Method for producing acidic xylooligosaccharide composition
JP3772749B2 (en) 2002-01-25 2006-05-10 王子製紙株式会社 Melanin production inhibitor
JP2003221339A (en) 2002-01-29 2003-08-05 Oji Paper Co Ltd Anti-inflammatory agent
ITMI20031618A1 (en) 2003-08-06 2005-02-07 Inalco Spa POLYSACCHARIDE DERIVATIVES EQUIPPED WITH HIGH ACTIVITY
JP5232470B2 (en) 2004-05-27 2013-07-10 バクスター・インターナショナル・インコーポレイテッド Method for treating bleeding disorders using sulfated polysaccharides
DK1778709T3 (en) 2004-08-05 2008-09-22 Ivax Drug Res Inst Ltd Polysulfated glycosides and their salts
US20060194759A1 (en) * 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
US20080214480A1 (en) 2005-07-22 2008-09-04 Trf Pharma, Inc. Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae
ES2913483T3 (en) 2006-04-03 2022-06-02 Ceva Animal Health Pty Ltd Stabilized pentosan polysulfate (PPS) formulations
GB0610350D0 (en) 2006-05-25 2006-07-05 Univ Liverpool prevention and/or treatment of neuodegenerative disorders
WO2008066193A1 (en) 2006-11-27 2008-06-05 Chisso Corporation Cosmetic composition
US20100105889A1 (en) 2007-03-06 2010-04-29 Pandurang Balwant Deshpande Process for the preparation of pentosan polysulfate or salts thereof
FI121811B (en) 2007-06-01 2011-04-29 Upm Kymmene Corp New dispersions and processes for their preparation
HUP0900072A2 (en) * 2009-02-06 2010-09-28 Egis Gyogyszergyar Nyilvanosan Transdermal pharmaceutical compositions
WO2009087581A1 (en) 2008-01-04 2009-07-16 Alembic Limited An improved process for the preparation of pentosan polysulfate or salts thereof
JP2009196915A (en) 2008-02-20 2009-09-03 Ezaki Glico Co Ltd Composition for cosmetic
AU2008100725B4 (en) * 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd A sulfated polysaccharide compound for clinical use
FR2935386B1 (en) 2008-08-26 2010-09-10 Sanofi Aventis NOVEL POLYSACCHARIDES WITH ANTITHROMBOTIC ACTIVITY COMPRISING A COVALENT LIAISON WITH AN AMINO CHAIN
ES2610240T3 (en) 2009-02-02 2017-04-26 Otsuka Chemical Co., Ltd. Low molecular weight polysulfated hyaluronic acid derivative and medicine containing it
CN102061323B (en) 2010-11-10 2013-09-25 山东龙力生物科技股份有限公司 Comprehensive utilization process of wood cellulose
WO2012101544A1 (en) 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium
CN102766225B (en) 2011-05-06 2015-08-05 上海医药工业研究院 A kind of piperylene gathers the preparation method of sodium sulfate and a kind of oligomeric xylose
WO2013186857A1 (en) 2012-06-12 2013-12-19 株式会社リボミック Aptamer to fgf2 and use thereof
ITMI20130112A1 (en) 2013-01-24 2014-07-25 Chemi Spa QUALIFICATION METHOD OF PENTOSAN POLYPHOSPHATE PREPARATIONS, ITS RAW MATERIALS AND PRODUCTION PROCESSES
JO3529B1 (en) 2013-02-08 2020-07-05 Amgen Res Munich Gmbh Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
JP6132302B2 (en) 2013-05-28 2017-05-24 リーディアント・バイオサイエンシーズ・ソシエタ・アノニマLeadiant Biosciences S.A. Derivatives of partially desulfated glycosaminoglycans as heparanase inhibitors with anti-angiogenic activity and no anticoagulant effect
CN103320548A (en) 2013-06-24 2013-09-25 稼禾生物股份有限公司 Method for preparing xylooligosaccharide and cellulose by using crop straws
JP6403317B2 (en) 2013-07-19 2018-10-10 学校法人慶應義塾 Antitumor agent
KR102692302B1 (en) 2015-05-20 2024-08-07 케미 에스.피.에이. Method for producing polysaccharide
AU2016267264A1 (en) 2015-05-27 2017-12-07 Vanguard Therapeutics, Inc. Pentosan polysulfate sodium for the treatment of sickle cell disease
CN106832020A (en) 2015-12-04 2017-06-13 长春工业大学 A kind of preparation technology of maize straw Pentosan sulphate
CN105907896B (en) 2016-05-16 2019-11-12 中国科学院广州能源研究所 A method of utilizing lignocellulose raw material coproduction high concentration xylose and xylo-oligosaccharide
JP6225321B1 (en) 2016-08-31 2017-11-08 王子ホールディングス株式会社 Method for producing polysulfate pentosan
CN111148749A (en) 2016-08-31 2020-05-12 王子控股株式会社 Production method of acidic xylo-oligosaccharide and acidic xylo-oligosaccharide
JP6281659B1 (en) 2017-02-28 2018-02-21 王子ホールディングス株式会社 Polysulfate pentosan, pharmaceutical composition and anticoagulant

Also Published As

Publication number Publication date
SG10201913607WA (en) 2020-03-30
BR112019025030A2 (en) 2020-06-16
CA3065747A1 (en) 2018-12-06
KR20240023711A (en) 2024-02-22
EP3632451A4 (en) 2021-03-10
US11278485B2 (en) 2022-03-22
WO2018221547A1 (en) 2018-12-06
JP6555431B2 (en) 2019-08-07
PH12019502676A1 (en) 2020-10-19
JPWO2018221547A1 (en) 2019-06-27
EP3632451A1 (en) 2020-04-08
KR20200011467A (en) 2020-02-03
US20200146963A1 (en) 2020-05-14
CN110678189A (en) 2020-01-10
AU2018276567B2 (en) 2021-09-16
MX2019014445A (en) 2020-02-10
AU2018276567A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
IL282304A (en) Topical pharmaceutical compositions
EP3328353A4 (en) Topical skin formulations
EP3324925A4 (en) Topical skin formulations
SG10201913607WA (en) Moisturizing topical preparation
EP3389624A4 (en) Topical cosmetic compositions
SG11202000615VA (en) Topical composition
SG11201706938XA (en) Topical formulation
IL266448A (en) Topical detomidine formulations
EP3328354A4 (en) Topical skin formulations
GB201502845D0 (en) Topical pharmaceutical formulation
ZA201803987B (en) Topical skin care compositions comprising myrsine africana extracts
EP3383912A4 (en) Topical formulations
PT3373976T (en) Topical formulations and uses thereof
IL268374A (en) Topical composition
SG10201913501RA (en) Liposomal formulations
IL272944A (en) Topical compositions
GB201713160D0 (en) Topical composition
IL252955A0 (en) Mouthrinse formulations
GB201513108D0 (en) Topical composition
GB201701970D0 (en) Topical composition
ZA201703472B (en) Mouthrinse formulations
AU2015901811A0 (en) Skin moisturizing composition
HUP1500251A2 (en) Moisturizing cosmetic composition
GB201608190D0 (en) Topical composition